Literature DB >> 14975515

Stress and dopamine: implications for the pathophysiology of chronic widespread pain.

Patrick B Wood1.   

Abstract

Fibromyalgia has been called a "stress-related disorder" due to the onset and exacerbation of symptoms in the context of stressful events. Evidence suggests that inhibition of tonic pain is mediated by activation of mesolimbic dopamine neurons, arising from the cell bodies of the ventral tegmental area and projecting to the nucleus accumbens. This pain-suppression system is activated by acute stress, via the release of endogenous opioids and substance P within the ventral tegmental area. However, prolonged exposure to unavoidable stress produces both reduction of dopamine output in the nucleus accumbens and development of persistent hyperalgesia. It is proposed that a stress-related reduction of dopaminergic tone within the nucleus accumbens contributes to the development of hyperalgesia in the context of chronic stress and thus plays a role in the pathogenesis of fibromyalgia. A stress-related dysfunction of mesolimbic dopaminergic activity might serve as the basis for other fibromyalgia-associated phenomena as well.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14975515     DOI: 10.1016/j.mehy.2003.10.013

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  33 in total

1.  Stress enhances muscle nociceptor activity in the rat.

Authors:  X Chen; P G Green; J D Levine
Journal:  Neuroscience       Date:  2011-04-15       Impact factor: 3.590

Review 2.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

Review 3.  [Cognitive impairment in patients suffering from fibromyalgia. An underestimated problem].

Authors:  T Schmidt-Wilcke; P Wood; R Lürding
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

4.  Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

Authors:  Kenneth Blum; Edward J Modestino; Rajendra D Badgaiyan; David Baron; Panayotis K Thanos; Igor Elman; David Siwicki; Marcelo Febo; Mark S Gold
Journal:  EC Psychol Psychiatr       Date:  2018-07-30

Review 5.  Fibromyalgia: present to future.

Authors:  Robert Bennett
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

6.  Mitigating the Effects of Electrode Biofouling-Induced Impedance for Improved Long-Term Electrochemical Measurements In Vivo.

Authors:  Blake T Seaton; Daniel F Hill; Stephen L Cowen; Michael L Heien
Journal:  Anal Chem       Date:  2020-04-16       Impact factor: 6.986

Review 7.  Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions.

Authors:  Amanda L-C Chen; Thomas J H Chen; Roger L Waite; Jeffrey Reinking; Howard L Tung; Patrick Rhoades; B William Downs; Eric Braverman; Dasha Braverman; Mallory Kerner; Seth H Blum; Nicholas DiNubile; David Smith; Marlene Oscar-Berman; Thomas J Prihoda; John B Floyd; David O'Brien; H H Liu; Kenneth Blum
Journal:  Med Hypotheses       Date:  2008-10-31       Impact factor: 1.538

8.  Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury.

Authors:  G J Norman; K Karelina; N Zhang; J C Walton; J S Morris; A C Devries
Journal:  Mol Psychiatry       Date:  2009-09-22       Impact factor: 15.992

9.  The impact of energy modulation on physical functioning and fatigue severity among patients with ME/CFS.

Authors:  Leonard Jason; Mary Benton; Susan Torres-Harding; Kathleen Muldowney
Journal:  Patient Educ Couns       Date:  2009-04-08

Review 10.  Imaging Pain.

Authors:  Katherine T Martucci; Sean C Mackey
Journal:  Anesthesiol Clin       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.